Venus Remedies Limited (BOM:526953)
India · Delayed Price · Currency is INR 1,780.10
-6.70 (-0.37%)
At close: Aug 17, 2026
Venus Remedies Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,028 | 453.15 | 284.91 | 265.66 | 407.24 |
Depreciation & Amortization | 175.67 | 225.06 | 264.43 | 322.98 | 335.34 |
Other Amortization | 81.04 | - | - | - | - |
Loss (Gain) From Sale of Assets | 6.19 | 10.84 | -0.56 | 4.83 | 0.97 |
Loss (Gain) From Sale of Investments | -59.37 | -16.28 | -5.51 | -0.08 | - |
Provision & Write-off of Bad Debts | - | - | 0.61 | - | - |
Other Operating Activities | 293.82 | 116.72 | 104.91 | 19.23 | -116.15 |
Change in Income Taxes | -342.68 | -149.22 | -154.83 | - | - |
Change in Other Net Operating Assets | 375.16 | 224.16 | -121.09 | -246.34 | -216.38 |
Operating Cash Flow | 1,558 | 864.42 | 372.85 | 366.27 | 411.02 |
Operating Cash Flow Growth | 80.20% | 131.84% | 1.80% | -10.89% | -68.82% |
Capital Expenditures | -376.56 | -96.27 | -93.18 | -78.18 | -137.08 |
Sale of Property, Plant & Equipment | 1.91 | 2 | 4.83 | 0.74 | 4.17 |
Sale (Purchase) of Intangibles | - | -84.52 | -42 | - | - |
Investment in Securities | -1,466 | -633.19 | 12.71 | -199.92 | -46.03 |
Other Investing Activities | 25.19 | 49.51 | 45.55 | -230.94 | 11.67 |
Investing Cash Flow | -1,816 | -762.48 | -72.09 | -508.3 | -167.27 |
Short-Term Debt Repaid | -16.93 | -9.54 | - | - | - |
Long-Term Debt Repaid | -8.38 | - | -9.89 | -4.5 | -90.16 |
Total Debt Repaid | -25.3 | -9.54 | -9.89 | -4.5 | -90.16 |
Net Debt Issued (Repaid) | -25.3 | -9.54 | -9.89 | -4.5 | -90.16 |
Other Financing Activities | -5.85 | -0.65 | -0.94 | -1.18 | -4.62 |
Financing Cash Flow | -31.15 | -10.19 | -10.83 | -5.68 | -94.77 |
Foreign Exchange Rate Adjustments | -34.95 | -6.08 | -12.5 | -72.74 | -5.21 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - |
Net Cash Flow | -324.07 | 85.68 | 277.44 | -220.44 | 143.76 |
Free Cash Flow | 1,181 | 768.15 | 279.67 | 288.09 | 273.94 |
Free Cash Flow Growth | 53.77% | 174.66% | -2.92% | 5.17% | -77.93% |
Free Cash Flow Margin | 15.35% | 11.77% | 4.65% | 5.19% | 4.56% |
Free Cash Flow Per Share | 88.36 | 57.47 | 20.92 | 21.55 | 20.76 |
Levered Free Cash Flow | 1,051 | 622.03 | 67.63 | 164.48 | 37.73 |
Unlevered Free Cash Flow | 1,051 | 622.44 | 68.21 | 165.22 | 39.62 |
Cash Interest Paid | 5.85 | 0.65 | 0.94 | 1.18 | 1.78 |
Cash Income Tax Paid | 342.68 | 149.22 | 154.83 | -212.12 | - |
Change in Working Capital | 32.48 | 74.94 | -275.92 | -246.34 | -216.38 |